Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-15
2005-02-15
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253060, C514S311000, C514S547000, C514S563000, C514S620000, C514S655000, C544S128000, C544S363000, C546S165000, C546S168000, C546S176000, C546S179000, C560S169000, C562S565000, C564S165000, C564S389000
Reexamination Certificate
active
06855711
ABSTRACT:
Use of a compound of formula (I), wherein R1is H or hydrocarbyl; R2is a hydrophobic radical; R3is 3-(C2-C6)acyl-4-hydroxyphenyl, 3-hydroxyimino (C2-C6)-alkyl-4-hydroxyphenyl, or COOZ, wherein Z is H, (C1-C6) alkyl, aryl, aryl or ar(C1-C6) alkyl; and n is 1-20; and of a compound of formula (II), wherein R4is (C1-C6) alkyl, cyano (C1-C6) alkyl, (C1-C6) alkoxy (C1-C6) alkyl or —CH2NR7R8, wherein R7and R8, the same or different, is each H or (C1-C6) alkyl, or together with the N atom form a saturated or unsaturated 5-7 membered ring optionally containing a further heteroatom selected from N, O or S, the further N atom being optionally substituted, and either R5is H and R6is (C2-C6) acyl or hydroxyimino (C2-C6) alkyl, or R5and R6together with the phenyl ring form a quinoline, a 1,2,3,4-tetrahydroquinoline or a perhydroquinoline ring, for the preparation of pharmaceutical compositions for the treatment of Parkinson's disease or stroke.
REFERENCES:
patent: 4652519 (1987-03-01), Warshawsky et al.
patent: 0 329 481 (1989-08-01), None
patent: 63-238060 (1988-10-01), None
Kahana N et al.: “A Conceptual Approach to the Synthesis of Bifunctional EDTA Analogsedta-Extended Polyamides”, Journal or Organic Chemistry, US, American Chemical Society, Easton, vol. 59, No. 17, Aug. 26, 1994, pp. 4832-4837, XP000576114.
Warshawsky A.: “Bifunctional Chelating Agents Part 3”, J. Chem. Soc. Perkin Trans. I, vol. 10, 1989, pp. 1781-1786 XP002155815.
Hall E D et al. “Neuroprotective Efficacy of Microvascularly-Localized Versus Brain-Penetrating Antioxidants.”, Acta Neurochirurgica. Supplementum, (1996) 66 107-13 Ref: 23, XP000972206.
Wesemann, W. (1) et al. “Effect of Lazaroid U-74389G on Iron-Induced Reduction of Striatal Dopamine Metabolism”, Journal Of Neural transmission Supplement, (1995) vol. 46, No. 0, pp. 175-182.
Ben-Shachar D et al. “Iron Melanin Interaction and Lipid Peroxidation Implications for Parkinson's Disease” J Neurochem, (1991) 57(5), 1609-1614, XP000972207.
Warshawskky A et al. “Cytotoxicity Effects of Transition-Metal Chelators of the 5-Substituted 2-Hydroxyacetophenones and Their Oximes”, European Journal Of Medicinal Chemistry, vol. 30, No. 7-8, 1995, pp. 553-560, XP002163945.
Kirienko, G. K. et al. “Derivatives of 8-Hydroxyquinoline as Possible Anthelmintics, Nematocides, and Fungicides” retrieved from STN, Database accession No. 70:106350 HCA, XP002163950 (1968).
Warner VD et al. “Quantitative Structure Activity Relationships for 5-Substituted 8-Hydroxyquinolines as Inhibitors of Dental Plaque”, Journal Of Medicinal Chemistry, (Jan. 1976) 19 (1) pp.92-96. XP002163946.
Warner V D et al. “Synthesis and in Vitro Evaluation of 8-Hydroxyquinoline Analogs as Inhibitors of Dental Plaque” Journal Of Medicinal Chemistry, (Jan. 1976) 19 (1) pp. 167-169.
Burckhalter et al. “Amino and Chloromethylation of 8-Quinolinol-Mechanism of Preponderant Ortho Substitution in Phenols Under Mannich Conditions”, Journal Of Organic Chemistry, vol. 26, Oct. 1961 pp. 4078-4083, XP002163948 p. 4078-4083.
Matsumura et al. “Condensation of Chloral Hydrate with 8-Quinolinol”, Journal Of The Americal Chemical Society, 1955, pp. 6671-6674, XP002163949.
Ben-Shachar Dorit
Warshawsky Rivka
Youdim Moussa B. H.
Browdy and Neimark , P.L.L.C.
Raymond Richard L.
Technion Research and Development Foundation Ltd.
Yeda Research and Development Co. Ltd.
LandOfFree
Pharmaceutical compositions comprising iron chelators for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions comprising iron chelators for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising iron chelators for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3467701